Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Neurodegenerative Disease Treatment Market Report by Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Huntington’s Disease, and Others), Drug Type (N-Methyl-D-Aspartate Receptor Antagonists, Selective Serotonin Reuptake Inhibitors, Dopamine Inhibitors, and Others), Route of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... of Administration (Oral, Injectable, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global neurodegenerative disease treatment market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Alzheimer’s Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnostics Technique (Biomarkers, Imaging Techniques), By Type (Triage, Diagnosis), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2
... Diagnostics Market Growth & Trends The global Alzheimer’s disease diagnostics market size is expected to reach USD 15.92 billion by 2030, registering a CAGR of 11.4% from 2024 to 2030, according to a new report ... Read More
-
Alzheimer's Drugs Market Report by Drug Class (Cholinesterase Inhibitors NMDA Receptor Antagonist Combination Drugs and Others), Drug Type (Galantamine, Donepezil, Memantine, Rivastigmine, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Company Analysis 2024-2032
... Company Analysis 2024-2032 The global Alzheimer's drug market reached US$ 6.95 Billion in 2023 and is expected to reach US$ 15.08 Billion through 2032, with a CAGR of 8.99 percent from 2024 to 2032. Alzheimer's ... Read More
-
Wearable EEG Headsets Market Size, Share & Trends Analysis Report By Application (Trauma & Surgery, Disease Diagnosis), By Product, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Trends The global wearable EEG headsets market size is expected to reach USD 244.9 million by 2030, growing at a CAGR of 10.47% from 2024 to 2030, according to a new report by Grand View ... Read More
-
Milk Beverage Market Size Outlook, 2024- by Type (Kefir, Butter Milk, Ayran, Others), Categories (Flavored Drink, Unflavored Drink), Distribution channel (Supermarkets, Convenience stores, Online Channels, Others), End User (Adult, Children, Hotels, Others)- Industry Growth, Trends, Opportunities, Share, and Companies Analysis to 2032 Report
... Opportunities, Share, and Companies Analysis to 2032 Report The Milk Beverage market is poised to register a CAGR of 6.15% between 2024 and 2032. The market growth is driven by steady demand and new product ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Neuroprosthetics Market Size, Trends, Analysis, and Outlook By Type (Output Neural Prosthetics, Input Neural Prosthetics), By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Others), By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, Others), by Country, Segment, and Companies, 2024-2032
... Processing Disorders, Ophthalmic Disorders, Others), by Country, Segment, and Companies, 2024-2032 The global Neuroprosthetics market size is poised to register 11.7% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the ... Read More
-
Neuroprotective Agents Market Size, Trends, Analysis, and Outlook By Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), By Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis, Others), By Route of Administration (Oral, Topical, Epidural, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), by Country, Segment, and Companies, 2024-2032 The global Neuroprotective Agents market size is poised to register 7.2% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Neurodegenerative Disease Market Size, Trends, Analysis, and Outlook By Indication (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Others), By Drug (N-methyl-D-aspartate Receptor Antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Others), by Country, Segment, and Companies, 2024-2032
... Companies, 2024-2032 The global Neurodegenerative Disease market size is poised to register 7.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neurodegenerative ... Read More
-
Global Clinical Nutrition Market Size Study & Forecast, By Product (Oral Clinical Nutrition, Parenteral Nutrition, Enteral Feeding Formulas) By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales (Retail Sales Channels, Online Sales Channels, Institutional Sales Channels) and Regional Analysis, 2023-2030
... Disorder/Diarrhea, Others), By Sales (Retail Sales Channels, Online Sales Channels, Institutional Sales Channels) and Regional Analysis, 2023-2030 Global Clinical Nutrition Market is valued at approximately USD 29.12 billion in 2022 and is anticipated to grow ... Read More
-
2024 Global Forecast for Alzheimer'S Disease Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Predictive Presymptomatic Testing Market Size, Trends, Analysis, and Outlook By Condition (Breast and Ovarian Cancer , Colorectal Cancer , Alzheimer's Disease , Multiple Endocrine Neoplasia Type 2 , Haemochromatosis), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Predictive Presymptomatic Testing market size is poised to register 9.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Melatonin Supplements Market Size, Trends, Analysis, and Outlook By Type (Tablet, Capsule), By Application (Alzheimer's Disease, Weak immune System, Osteoporosis, Cancer Treatment, Nerve Pain, Others), By Distribution Channel (Supermarkets and Hypermarkets, Departmental Stores, Specialty Shops, E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030
... E Commerce Platforms), By End-User (Pharmaceuticals, Food and Beverage, Medical and Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Melatonin Supplements market size is poised to register 12.8% growth (CAGR) from 2024 ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029
... projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues due to the growing geriatric population ... Read More
-
Oral Clinical Nutrition Market Size, Trends, Analysis, and Outlook By Stage (Adults, Pediatrics), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030
... (Online Sales, Retail Sales, Institutional Sales), by Region, Country, Segment, and Companies, 2024-2030 The global Oral Clinical Nutrition market size is poised to register 6.09% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Brain Implants Market Size, Trends, Analysis, and Outlook By Product (Deep Brain Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Chronic pain, Epilepsy, Parkinson's, Depression, Essential Tremor, Alzheimer's), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Brain Implants market size is poised to register 10.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Brain Implants ... Read More
-
Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030
... diagnostic centers, Research Organizations, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Neurological Biomarkers market size is poised to register 14.63% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Drug Delivery Across Blood-Brain Barrier Market Size, Trends, Analysis, and Outlook By Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Others), By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030
... Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug Delivery Across Blood-Brain Barrier market size is poised to register 19.61% growth from 2024 to 2030, ... Read More
Research Assistance
